Automated video support for smoking cessation in people with HIV
Randomized Trial of Automated Video-Assisted Smoking Treatment for People Living with HIV
This study is looking at whether a new smartphone program can help people living with HIV quit smoking better than regular treatments like counseling and nicotine patches, so if you're interested in trying a tech-friendly way to stop smoking, this might be for you!
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | H. Lee Moffitt Cancer Ctr & Res Inst NIH-funded |
| Lab location | 1 site (Tampa, United States) |
| Project ID | NIH-10909045 on NIH RePORTER |
What this research studies
This research investigates the effectiveness of an automated smartphone intervention designed to help individuals living with HIV quit smoking. Participants will be randomly assigned to receive either standard treatment, which includes counseling and nicotine replacement therapy, or the new automated video-assisted treatment. The goal is to determine if this innovative approach can improve smoking cessation rates among people living with HIV, who are at higher risk for cardiovascular diseases and cancers. By leveraging mobile technology, the study aims to provide a scalable and accessible solution for smoking cessation.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals living with HIV who smoke and are seeking assistance to quit.
Not a fit: Patients who do not smoke or are not living with HIV may not receive any benefit from this research.
Why it matters
Potential benefit: If successful, this research could significantly improve smoking cessation rates among people living with HIV, leading to better overall health outcomes.
How similar studies have performed: Previous research has shown promise in using mobile health applications for smoking cessation, but this specific approach targeting HIV-positive individuals is relatively novel.
Where this research is happening
Tampa, United States
- H. Lee Moffitt Cancer Ctr & Res Inst — Tampa, United States (Active)
Researchers
- Principal investigator: Vidrine, Damon J. — H. Lee Moffitt Cancer Ctr & Res Inst
- Study coordinator: Vidrine, Damon J.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.